Artivion (AORT) Amortization of Deferred Charges (2019 - 2022)
Artivion (AORT) posted Amortization of Deferred Charges of $460000.0 for Q4 2022, up 2400.0% on a QoQ basis from -$20000.0 in Q4 2021, and up 2400.0% year-over-year from $18400.0 in Q4 2021.
Artivion (AORT) Amortization of Deferred Charges (2019 - 2022) Analysis & Trends
Artivion's Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $460000.0 for Q4 2022.
- Quarterly Amortization of Deferred Charges rose 2400.0% year-over-year to $460000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $2.2 million (changed N/A YoY) and the FY2025 annual result came in at $1.7 million, down 55.9% from the prior year.
- Amortization of Deferred Charges was $460000.0 for Q4 2022 at Artivion, up from -$20000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $1.4 million in Q4 2020 and bottomed at -$20000.0 in Q4 2021.
- A 4-year average of $550000.0 and a median of $412500.0 in 2019 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2021 — Amortization of Deferred Charges plunged 101.43% — and 2022, when it jumped 2400.0%.
- Artivion's Amortization of Deferred Charges stood at $365000.0 in 2019, then jumped by 282.19% to $1.4 million in 2020, then plunged by 101.43% to -$20000.0 in 2021, then soared by 2400.0% to $460000.0 in 2022.
- Business Quant data shows AORT's Amortization of Deferred Charges at $460000.0 in Q4 2022, -$20000.0 in Q4 2021, and $1.4 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn |
| 10 | Artivion | 1.25 Bn | 1.20 Bn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 460,000.00 |
| Dec 31, 2022 | 460,000.00 |
| Dec 31, 2021 | -20,000.00 |
| Dec 31, 2021 | -20,000.00 |
| Dec 31, 2020 | 1.40 Mn |
| Dec 31, 2020 | 1.40 Mn |
| Dec 31, 2019 | 365,000.00 |
| Dec 31, 2019 | 365,000.00 |